Ami Organics Ltd
P&L
Quarterly Consolidated
vs Q1 FY26
Acutaas Chemicals Q2 FY26 Revenue from Operations at Rs. 3,062 mn, up 24.1% YoY
17 Oct 2025 · 17 Oct 2025, 12:27 pm
Summary
Acutaas Chemicals Limited, a leading global manufacturer of advance pharmaceutical intermediates and speciality chemicals, announced financial results for the quarter and half year ended September 30, 2025. The company reported a 24.1% YoY increase in revenue from operations, reaching Rs. 3,062 mn. The EBITDA margin expanded by 1130 bps YoY to 31.1%.
Key Highlights
- 1
Revenue from operations for Q2FY26 grew by 24.1% YoY to Rs. 3,062 mn
- 2
Gross margin for the quarter improved to 55.8% up 1,232 bps YoY
- 3
EBITDA for the quarter came at Rs. 953 mn up 94.8% YoY
- 4
EBITDA margin for the quarter was at 31.1% as compared to 19.8% in Q2FY25
- 5
PAT for the quarter was Rs. 719 mn up 91.3% as compared to PAT of Rs. 376 mn in Q2FY25
- 6
The PAT margin for the quarter was at 23.5% up 824 bps YoY
- 7
Export for the quarter at 76%; domestic business at 24%
Management Comments
Mr. Naresh Patel
Our focus has always been on building a long-term, sustainable business rather than chasing short-term opportunities. This disciplined approach is now yielding tangible results as we strengthen global partnerships and expand into new growth verticals such as Battery Chemicals and Semiconductors. In Q2 FY26, our revenue grew by 24.1% year-on-year to %3,062 million, driven by strong performance in Advanced Pharmaceutical Intermediates and stable contributions from Specialty Chemicals. We remain confident of delivering around 25% revenue growth for the full year, backed by a resilient business foundation and clear strategic direction
Informational and educational content only. Not investment advice.